Information Registration Programme Overview Satellite Education Programme Virtual Exhibitor Listing


All ePoster presentations will be available to view anytime throughout the Meeting in an Online Library

Search Abstracts by author or title


Functional and anatomical results and safety profile of Carlevale intraocular lens implantation in patients with insufficient capsular support

Poster Details

First Author: A. Dyrda SPAIN

Co Author(s):    M. Pighin   J. Reyes-Torres   A. Rey   I. Jürgens           

Abstract Details


To evaluate the outcomes of Carlavale intraocular lens (IOL) implantation.


Institut Catal� de Retina, Barcelona, Spain


Consecutive patients with insufficient capsular support were included. All patients underwent 25-gauge pars plana vitrectomy with Carlevale IOL implantation in a single procedure. The main outcome measures were corrected distance visual acuity (CDVA), spherical equivalent (SE), astigmatism, prediction error (PE) and absolute error (AE), horizontal and vertical tilt with ultrasound biomicroscopy (UBM), as well as intra- and postoperative complications.


20 patients were included. Mean age and follow-up were 67.1 � 12.8 and 4 � 2.5, respectively. Median CDVA improved from 0.5 logMAR to 0.2 logMAR; however, when ocular comorbidities affecting VA were excluded, this improved to 0.07 logMAR. Mean postoperative SE, astigmatism, PE and AE were 0.75�0.625 D, 0�-0.25 D, -0.06�0.89 and 0.71�0.51, respectively. There was no IOL tilt in UBM. One vitreous haemorrhage (VH, 5%) was observed intraoperatively and 1 VH (5%), 1 choroidal detachment (5%), 4 cases (20%) of ocular hypertension, 2 cystic macular oedema (10%) and 1 surgery of exposed haptic (5%), were detected postoperatively.


Carlevale implantation provided good visual results, predictability of refractive outcomes and IOL stability. The safety profile was acceptable. We suggest that it should be considered as the first option for sutureless scleral fixation (SSF) in the absence of capsular support, especially as Carlevale is specifically designed and approved IOL for SSF.

Financial Disclosure:


Back to Poster listing